Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
59.35
+2.09 (3.65%)
Jan 23, 2026, 3:00 PM CST
SHA:688580 Revenue
Nanjing Vishee Medical Technology had revenue of 115.08M CNY in the quarter ending September 30, 2025, with 14.87% growth. This brings the company's revenue in the last twelve months to 433.83M, up 2.75% year-over-year. In the year 2024, Nanjing Vishee Medical Technology had annual revenue of 400.06M, down -13.45%.
Revenue (ttm)
433.83M
Revenue Growth
+2.75%
P/S Ratio
13.09
Revenue / Employee
678.92K
Employees
632
Market Cap
5.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 400.06M | -62.16M | -13.45% |
| Dec 31, 2023 | 462.22M | 140.60M | 43.72% |
| Dec 31, 2022 | 321.62M | -108.42M | -25.21% |
| Dec 31, 2021 | 430.04M | 51.68M | 13.66% |
| Dec 31, 2020 | 378.37M | 59.49M | 18.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Wuhan Huakang Century Clean Technology | 2.06B |
| Shenzhen Lifotronic Technology | 1.05B |
| Getein Biotech | 1.04B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Shanghai Aohua Photoelectricity Endoscope | 671.62M |
| Hangzhou AGS MedTech | 668.70M |
| Contec Medical Systems Co.,Ltd | 489.91M |